QAU Faculty | Pharmacy | Dr. Salman Khan

Research Interests Publications Conferences Research Projects

Neuropharmacology & Analgesia, Immuno-Molecular Pharmacology, Biochemical-Systemic Pharmacology

RESEARCH/REVIEW PUBLICATIONS (SCI/IF)

Author (s), title	Journal, Vol. No., Page No., Country	Year	Impact factor
1. M Zeeshan, A Atiq, Q Ain, J Ali, Salman Khan, H Ali. Evaluating the mucoprotective efects of glycyrrhizic acid‑loaded polymeric nanoparticles in a murine model of 5‑fuorouracil‑induced intestinal mucositis via suppression of infammatory mediators and oxidative stress. *(Co-author)**	Inflammopharmacology (2021). https://doi.org/10.1007/s10787-021-00866-z	2021	4.473
2. Y, A Khan, O Shehzad; EK Seo, A Onder, Salman Khan. Anti-allergic activities of Umbelliferone against Histamine and Picryl chloride-induced ear edema by targeting Nrf2/iNOS signaling in mice. *(Corresponding author)**	BMC Complementary Medicine and Therapies 21:215 https://doi.org/10.1186/s12906-021-03384-1	2021	3.47
3. A Khan, A Khan, A Khan, B Shal, A Aziz, MN Ahmed, S Ul Islam, H Ali, A Shehzad, Salman Khan. Inhibition of NF-κB signaling and HSP70/HSP90 proteins by newly synthesized hydrazide derivatives in arthritis model. *(Corresponding author)**	Naunyn-Schmiedeberg’s Archives of Pharmacology, 394(7), 1497-1519	2021	5.923
4. B Shal, A Khan, A Khan, R Ullah, GAli, S Islam, I Haq, H Ali, E-K Seo, and Salman Khan. Alleviation of Memory Deficit by Bergenin via the Regulation of Reelin and Nrf-2/NF-κB Pathway in Transgenic Mouse Model. *(Corresponding author)**	International Journal of Molecular Sciences 22, 6603. https://doi.org/10.3390/ijms22126603	2021	5.923
5. A Khan, B Shal, A Khan, R Ullah, M W Baig, I Haq, EK Seo, Salman Khan. Suppression of TRPV1/TRPM8/P2Y nociceptors by withametelin via downregulating MAPK signaling in mouse model of vincristine-induced neuropathic pain. *(Corresponding author)**	International Journal of Molecular Sciences 22(11), 6084; https://doi.org/10.3390/ijms22116084	2021	3.00
6. M Zeeshan, H Ali, Q Ain, M Mukhtar, R Gul, A Sarwar, Salman Khan. A holistic QBD approach to design galactose conjugated PLGA polymer and nanoparticles to catch macrophages during intestinal inflammation. *(Co-author)**	Materials Science and Engineering: C, Vol 126, 112183	2021	7.328
7. E Sana, M Zeeshan, Q Ain, A Khan, I Hussain, Salman Khan, E Lepeltier & H Ali. Topical delivery of curcumin-loaded transfersomes gel ameliorated rheumatoid arthritis by inhibiting NF-κβ pathway *(Co-author)**	Nanomedicine (Lond.) 10.2217/nnm-2020-0316	2021	5.307
8. I Liaquat, A Khan, Salman Khan. Pharmacological evaluation of continentalic acid for antidiabetic potential. *(Co-author)**	Biomedicine & Pharmacotherapy 138, 111411	2021	6.529
9. F Rehman, K Mazhar, A Malik, SS Naz, K Ullah Shah, A Khan, Salman Khan, R Ahmed, S Qaisar. Surface multifaceted nanocarriers for oral non-conventional cancer therapy; synthesis and evaluation. *(Co-author)**	Materials Science and Engineering: C, Vol 123, 111940	April 2021	7.328
10. A Shehzad, SU Islam, R Shahzad, Salman Khan, YS Lee. Extracellular vesicles in cancer diagnostics and therapeutics. *(Co-author)**	Pharmacology & Therapeutics Vol 223, 107806	July, 2021	12.310
11. SZ Khan, Z Khan, I Ahmad, S Khan, Salman Khan, M Ahmad, M Inam, F B-Gariepy, Z Rehman. Structural Features, Anticancer, Antioxidant and Anti-acetylcholinesterase Studies of [(DTCs)(PAr₃)PdCl]. *(Co-author)**	Inorganic Chemistry Communications 123, 108316	January 2021	2.495
12. A Khan, A Khan, S Khalid, B Shal, E Kang, H Lee, G Laumet, EK Seo, Salman Khan. 7β-(3-ethyl-cis-crotonoyloxy)-1α-(2-methylbutyryloxy)-3,14-dehydro-Z Notonipetranone Attenuates Neuropathic Pain by Suppressing Oxidative Stress, Inflammatory and Pro-Apoptotic Proteins Expression. *(Corresponding author)**	Molecules. 1;26(1):181	January, 2021	4.411
13. H Ali, A Khan, J Ali, H Ullah, A Khan, H Ali, N Irshad and Salman Khan. Attenuation of LPS-induced acute lung injury by continentalic acid in rodents through inhibition of inflammatory mediators correlates with increased Nrf2 protein expression. (*Corresponding author)	BMC Pharmacology and Toxicology 21(1):81 DOI: 10.1186/s40360-020-00458-7	November 2020	2.483
14. AU Khan, A Muhammad, A Khan, B Shal, A Aziz, MN Ahmed, Salman Khan. The newly synthesized compounds (NCHDH and NTHDH) attenuate LPS-induced septicemia and multi-organ failure via Nrf2/HO1 and HSP/TRVP1 signaling in mice. (*Corresponding author)	Chemico-Biological Interactions Volume 329, 25, 109220	September 2020	5.192
15. M Mukhtar, M Zeeshan, Salman Khan, G Shahnaz, SA Khan, HS Sarwar, RA Pasha & H Ali. Fabrication and optimization of pH sensitive mannose-anchored nano-vehicle as a promising approach for macrophage uptake. *(Co-author)**	Applied Nanoscience 10:4013–4027	2020	3.674
16. Z Kazmi, S Zeeshan, A Khan, S Malik, A Shehzad, EK Seo, Salman Khan. Anti-epileptic activity of daidzin in PTZ-induced mice model by targeting oxidative stress and BDNF/VEGF signalling. *(Corresponding author)**	Neurotoxicology 79, 150-163	2020	4.294
17. A Khan, B Shal, M Naveed, B Nasir, N Irshad, H Ali, and Salman Khan. Matrine alleviates neurobehavioral alterations via modulation of JNK-mediated caspase-3 and BDNF/VEGF signaling in a mouse model of burn injury. *(Corresponding author)**	Psychopharmacology Psychopharmacology (Berl), 237(8):2327-2343	August, 2020	4.532
18. B Shal, A Khan, M Naveed, H Ali, H Choi, EK Seo, Salman Khan. Neuroprotective effect of 25-Methoxyhispidol A against CCl4-induced behavioral alterations by targeting VEGF/BDNF and caspase-3 in mice. *(Corresponding author)**	Life Sciences Volume 253, 15 July 2020, 117684	July, 2020	5.037
19. H Ullah, A Khan, MW Baig, N Ullah, N Ahmed; M K Tipu, H Ali, Salman Khan. Poncirin attenuates CCL-4-induced liver injury through inhibition of oxidative stress and inflammatory cytokines in mice. *(Corresponding author)**	BMC-Complementary Medicine and Therapy, 20:115 DOI: 10.1186/s12906-020-02906-7	April, 2020	3.47
20. M Qindeel, D Khan, N Ahmed, Salman Khan, A Rehman. Surfactant free, self-assembled nanomicelles-based transdermal hydrogel for safe and targeted delivery of methotrexate against rheumatoid arthritis. *(Co-author)**	ACS NANO 28;14(4):4662-4681.	March, 2020	15.881
21. AM Khan, A Khan, H Ali, S Islam, EK Seo, Salman Khan. Continentalic Acid Exhibited Nephroprotective Activity Against the LPS and E. Coli-Induced Kidney Injury Through Inhibition of the Oxidative Stress and Inflammation. *(Corresponding author)**	International Immunopharmacology 80, 106209	March, 2020	4.932
22. D Khan, M Qindeel, N Ahmed, A Khan1, Salman Khan and Asim.ur.Rehman. Development of novel pH-sensitive nanoparticle-based transdermal patch for management of rheumatoid arthritis. (Co-author)**	Nanomedicine (London) 15(6):603-624.	Feb, 2020	5.307
23. J Ali, A Khan, FA Shah, H Ali, S Islam, YS Kim and Salman Khan. Mucoprotective effects of Saikosaponin-A in 5-fluorouracil-induced intestinal mucositis in mice model. *(Corresponding author)**	Life Sciences 19; 239:116888.	2019	5.037
24. N Shah, T Zaman, T Rehan, Salman Khan, W Khan, A Khan, MU Islam. Preparation and Characterization of Agar Based Magnetic Nanocomposite for Potential Biomedical Applications. *(Co-author)**	Current Pharmaceutical Design. 25(34):3672-3680.	Oct 11, 2019.	3.116
25. R Afridi, A Khan, S Khalid, B Shal, H Rasheed, MZ Ullah, O Shehzad, YS Kim & Salman Khan. Anti-hyperalgesic properties of a flavanone derivative Poncirin in acute and chronic inflammatory pain models in mice. *(Corresponding author)**	BMC Pharmacology and Toxicology, vol.20, Article number: 57	2019	2.483
26. Q Ain, M Zeeshan, Salman Khan, H Ali. Biomimetic hydroxyapatite as potential polymeric nanocarrier for the treatment of rheumatoid arthritis. *(Co-author)**	Journal of Biomedical Materials Research - Part A 107(12):2595-2600.	August 2019	4.396
27. S Khalid, A Khan, B Shal, H Ali, YS Kim, Salman Khan. Suppression of TRPV1 and P2Y nociceptors by honokiol isolated from Magnolia officinalis in 3rd degree burn mice by inhibiting inflammatory mediators. *(Corresponding author)**	Biomedicine & Pharmacotherapy Volume 114, 108777	June, 2019	6.529
28. A Khan, Salman Khan, H Ali, K Shah, H Ali, O Shehzad, A Onder, YS Kim. Anomalin attenuates LPS-induced acute lungs injury through inhibition of AP-1 signaling. *(Corresponding author and 1^st author)**	International Immunopharmacology 73 (2019) 451–460 USA	May, 2019	4.932
29. S Zeeshan, M Naveed, A Khan, A Atiq, M Arif, MN Ahmed, YS Kim, Salman Khan. N-Pyrazoloyl and N-thiopheneacetyl hydrazone of isatin exhibited potent anti-inlammatory and anti-nociceptive properties through suppression of NF-κB, MAPK and oxidative stress signaling in animal models of inflammation. *(Corresponding author)**	Inflammation Research 68:613–632 Canada	May 2019	4.575
30. M Saqlain, A Riaz, MN Malik, Salman Khan, Al Ahmed, S Kamran, H Ali. Medication adherence and its association with health literacy and performance in activities of daily livings among elderly hypertensive patients. *(Co-author)**	Medicina 55, 163; doi:10.3390/medicina55050163 Republic of Lithuania	May 2019	2.430
31. M Zeeshan, H Ali, M Arshad, M Ijaz Khan, M Mukhtar, Salman Khan. Glycyrrhizic acid loaded pH-sensitive PLGA nanoparticles for the amelioration of inflammatory bowel disease. *(Co-author)**	Nanomedicine Vol 14(15), 1945–1969)	2019	5.307
32. M Naveed, A Khan, B Shal, S Zeeshan, Khan A, Shal B, Atiq A, Ali H, Ullah R, Zia-Ur-Rehman, Salman Khan. A new cationic palladium (II) dithiocarbamate exhibits anti-inflammatory, analgesic and antipyretic activities through inhibition of inflammatory mediators in in vivo models. *(Corresponding author)**	Naunyn-Schmiedeberg’s Archives of Pharmacology (2019) 392:961–977	March 09, 2019	4.294
33. B Shal, A Khan, M Naveed, N Khan, I Haq, SD Al-Sharari, YS Kim, Salman Khan. Effect of 25-methoxy hispidol A isolated from Poncirus trifoliate against bacteria-induced anxiety and depression by targeting neuroinflammation, oxidative stress and apoptosis in mice. *(Corresponding author)**	Biomedicine & Pharmacotherapy 111, 209-223. USA	March, 2019	6.529
34. M Zeeshan, H Ali, Salman Khan, SA Khan, B Weigmann. Advances in orally-delivered pH-sensitive nanocarrier systems; an optimistic approach for the treatment of inflammatory bowel disease. *(Co-author)**	International Journal of Pharmaceutics. 10; 558:201-214. France	March, 2019	5.875
35. A Khan, B Shal, M Naveed, FA Shah, A Atiq, N Ullah Khan, YS Kim, Salman Khan. Matrine ameliorates anxiety and depression-like behaviour by targeting hyperammonemia-induced neuroinflammation and oxidative stress in CCl4 model of liver injury. *(Corresponding author)**	Neurotoxicology. 8; 72:38-50. USA	February, 2019	4.294
36. A Khan, M Zia Ullah, R Afridi, H Rasheed, S Khalid, H Ullah, H Ali, S AlSharari, Y S Kim, Salman Khan. Antinociceptive properties of 25‐methoxy hispidol A, a triterpinoid isolated from Poncirus trifoliata (Rutaceae) through inhibition of NF‐κB signalling in mice. *(Corresponding author)**	Phytotherapy Research. 2019; 33:327–341. USA	February, 2019	5.878
37. A Khan, Salman Khan, YS Kim. Insight of Pain modulation: nociceptors sensitization and therapeutic targets. *(Corresponding author)**	Current Drug Targets. 20(7):775-788.	January 30, 2019	3.465
38. A Atiq, B Shal, M Naveed, A Khan, J Ali, S Zeeshan. SD. Al-Sharari, YS Kim, Salman Khan. Diadzein ameliorates 5-fluorouracil-induced intestinal mucositis by suppressing oxidative stress and inflammatory mediators in rodents. *(Corresponding author)**	European Journal of Pharmacology, 843, 15, 292-306 Netherland	January 2019	4.432
39. S Khalid, MA Zahid, H Ali, YS Kim, Salman Khan. Biaryl scaffold-focused virtual screening for anti-aggregatory and neuroprotective effects in Alzheimer’s disease. *(Corresponding author)**	BMC Neuroscience 13;19(1):74.	November, 2018	3.288
40. M Zia ullah, A Khan, R Afridi, H Rasheed, S Khalid, M Naveed, H Ali YS Kim, Salman Khan. Attenuation of inflammatory pain by Puerarin in animal model of inflammation through inhibition of pro-inflammatory mediators. *(Corresponding author)**	International Immunopharmacology-61:306-316 (USA)	2018	4.932
41. H Rasheed, R Afridi, A Khan, M Z Ullah, S Khalid, A Atiq, H Kashif, M Naeem Ahmed, Y S Kim, Salman Khan. Anti-inflammatory, anti-rheumatic and analgesic activities of 2-(5-mercapto-1,3,4-oxadiazol-2-yl)-N-propylbenzenesulphonamide (MOPBS) in rodents. *(Corresponding author)**	Inflammopharmacology; 26:1037–1049. (UK)	2018	4.473
42. B Shal, W Ding, H Ali, YS Kim, Salman Khan. Anti-neuroinflammatory potential of natural products in attenuation of Alzheimer’s disease. *(Corresponding author)**	Frontiers in Pharmacology- 9, Article 548. doi: 10.3389/fphar.2018.00548(Switzerland).	2018	5.810
43. S Khalid, M Z. Ullah, A Khan, R Afridi, H Rasheed, A Khan, H Ali, YS Kim, and Salman Khan. Antihyperalgesic Properties of Honokiol in Inflammatory Pain Models by Targeting of NF-κB and Nrf2 Signaling. *(Corresponding author)**	Frontiers in Pharmacology, Vol 09 /article-140. doi: 10.3389/fphar.2018.00140(Switzerland)	2018	5.810
44. Salman Khan, RJ Choi, JH Lee, YS Kim. Attenuation of neuropathic pain and neuroinflammatory responses by a pyranocoumarin derivative in animal and cellular models. *(Corresponding author)**	European Journal of Pharmacology 774, 95–104. (Netherland)	2016	4.432
45. Salman Khan, O Shehzad, R Li, MS Cheng, and YS Kim. Pharmacological mechanism underlying anti-inflammatory properties of two structurally divergent coumarins through inhibition of pro-inflammatory enzymes and cytokines. *(1^st author)**	Journal of Inflammation, 29; 12:47. (UK)	2015	4.981
46. Salman Khan, O. Shehzad, J. Chun, R, J. Choi, M. N. Islam, J. S. Choi, and Y. S. Kim. Anti-hyperalgesic and anti-allodynic activities of capillarisin via suppression of inflammatory signaling in animal model. *(1^st author)**	Journal of Ethnopharmacology, 28;152(3):478-86). (Netherland)	2014	4.360
47. Salman Khan, O. Shehzad, K. J. Lee, A. Tosun, Y. S. Kim Anti-inflammatory properties of samidin from Sesli resinosm though suppression of NF-κB and AP-1-mediated-genes in LPS-stimulated RAW 264.7 cells. *(1^st author)**	Archive of Pharmacal Research, 37(11):1496-503. (South Korea)	2014	4.946
48. R. J Choi, J. Chun, Salman Khan and Y. S. Kim. Desoxyrhapontigenin, a potent anti-inflammatory phytochemical, inhibits LPS-induced inflammatory responses via suppressing NF-κB and MAPK pathways in RAW 264.7 cells. *(Co-author)**	International Immunopharmacology, 18,182–190. (USA)	2014	4.932
49. A Tosun, Salman Khan, YS Kim, á Calín-Sánchez, X Hysenaj and Aá Carbonell-Barrachina. I Essential Oil Composition and Anti-Inflammatory Activity of Salvia officinalis L (Lamiaceae) in Murin Macrophages. *(Co- author)**	Tropical Journal of Pharmaceutical Research, 13 (6): 937-942. (Africa).	2014	0.533
50. Salman Khan, O. Shehzad, J. Chun, Y. S. Kim Mechanism underlying anti-hyperalgesic and anti-allodynic properties of anomalin in both acute and chronic inflammatory pain models in mice through inhibition of NF-κB, MAPKs and CREB signaling cascades. *(1^st author)**	European Journal of Pharmacology, 718, 448–458. (Netherland)	2013	4.432
51. Salman Khan, R. J. Choi, O. Shehzad, H. P. Kim, M. N. Islam, J. S. Choi, and Y. S. Kim. Molecular mechanism of capillarisin-mediated inhibition of MyD88/TIRAP inflammatory signals in in vitro and in vivo experimental models. *(1^st author)**	Journal of Ethnopharmacology, 145, 626–637. (Netherland)	2013	4.360
52. O. Shehzad, Salman Khan, I.J. Ha, Y. Park, A. Tosun, Y. S. Kim.Application of stepwise gradients in counter-current chromatography: A rapid and economical strategy for the one-step separation of eight coumarins from Seseli resinosum. *(Co-author)**	Journal of Chromatography A, 1310 66–73. (USA)	2013	4.759
53. R. J. Choi, T. M. Ngoc, K. Bae, H. J. Cho, D. D. Kim, J. Chun, Salman Khan, Y. S. Kim. Anti-inﬂammatory properties of anthraquinones and their relationship with the regulation of P-glycoprotein function and expression. *(Co-author)**	European Journal of Pharmaceutical Sciences, 48, 272–281. (Netherland)	2013	4.432
54. Salman Khan, O. Shehzad, E. R. Woo, S. S. Kang, S. W. Baek, J. Kim, Y. S. Kim. Anti-inflammatory Mechanism of 15,16-Epoxy-3α-hydroxylabda-8,13(16),14-trien-7-one via Inhibition of LPS-Induced Multicellular Signaling Pathways. *(1^st author)**	Journal of Natural Products, 75, 67−71. (USA)	2012	4.050
55. J. Chun, R. J. Choi, Salman Khan, D. S. Lee, Y.C Kim, Y. J Nam, D. U Lee, Y. S. Kim. Alantolactone suppresses inducible nitric oxide synthase and cyclooxygenase-2 expression by down-regulating NF-κB, MAPK and AP-1 via the MyD88 signaling pathway in LPS-activated RAW 264.7 cells. *(Co-author)**	International Immunopharmacology, 14(4):375-83. (USA)	2012	4.932
56. O. Shehzad, Salman Khan, I. J. Ha, Y. Park, Y. S. Kim. Rational development of a selection model for solvent gradients in single-step separation of ginsenosides from Panax ginseng using high-speed counter-current chromatography. *(Co-author)**	Journal of Separation Science, 35, 1462–1469. (USA)	2012	3.645
57. Shehzad, Salman Khan, Y. S Lee. Curcumin molecular targets in obesity and obesity related cancer. *(Co-author)**	Future Oncology, 8(2), 1-12. (USA)	2012	3.404
58. Salman Khan, E. M. Shin, Y. H. Jung, J. Kim, A. Tosun, Y. S. Kim. Suppression of LPS-induced inflammatory and NF-κB responses by anomalin in RAW 264.7 macrophages. *(1^st author)**	Journal of Cellular Biochemistry, 112(8):2179-88. (USA)	2011	4.429
59. O. Shehzad, Salman Khan, T. Khan and JK Park. Physicochemical and mechanical characterization of bacterial cellulose produced with an excellent productivity in static conditions using a simple fed-batch cultivation strategy. *(Co-author)**	Carbohydrate Polymers, 82, 173-180. (USA)	2010	9.381
60. Shehzad, Salman Khan, O. Shehzad, and Y. S. Lee. Curcumin therapeutic promises and bioavailability in colorectal cancer. *(Co-author)**	Drugs of Today, 46(7): 523. (Spain)	2010	2.245
61. O. Shehzad, Salman Khan, T. Khan, and JK. Park Production of bacterial cellulose in static conditions by a simple fed-batch cultivation strategy. *(Co-author)**	Korean Journal of Chemical Engineering, Korean J. Chem. Eng., 26(6), 1689-1692 (Korea)	2009	3.309
62. J. K. Park, O. Shehzad, T. Khan, Salman Khan. Production of bacterial cellulose by G.hasenii using a new bioreactor equipped with centrifugal impellers. *(Co-author)**	Journal of Biotechnology, 136S, S460–S495. (USA)	2008	3.307
63. T. Khan, Salman Khan, J. K. Park. Simple fed-batch cultivation strategy for the enhanced production of single-sugar glucuronic acid-based oligosaccharides by a cellulose-producing Gluconacetobacter strain. *(Co-author)**	Biotechnology and Bioprocess Engineering, 13, 240-247. (Korea)	2008	2.836
64. J. H. Ha, O. Shehzad, Salman Khan, S.Y. Lee, J. W. Park, T. Khan, J.K. Park. Production of bacterial cellulose by a static cultivation using the waste from beer culture broth, Production of bacterial cellulose by a static cultivation using the waste from beer culture broth. (*Co-author)	Korean Journal of Chemical Engineering. 25(4), 812-815.	2008	3.309
	Total Impact Factor		311.69

PUBLICATIONS (NON-SCI)

Author (s), title	Journal, Vol. No., Page No., Country	Year	Impact factor
1. F Shahid, M Ismail, Salman Khan. Assessment of quality of life in post burn survivors: A cross-sectional single-center first validation study from Pakistan. *(Corresponding author)**	Burns Open, 2 (1), 35-42. (USA)	2018	00
2. Salman Khan and Y. S. Kim. Molecular mechanism of inflammatory signaling and predominant role of Saposhnikovia divaricata as anti-inflammatory potential. *(1^st author)**	Natural Product Sciences, 19(2): 1-7. (Korea)	2013	00
3. Salman Khan, A. Shehzad, O. Shehzad, and E. A Al-Suhaimi. Inpatient antibiotics pharmacology and physiological use in Hayatabad Medical Complex, Pakistan. *(1^st author)**	International Journal of Physiology, Pathophysiology and Pharmacology, 5(2):120-127). (USA)	2013	00
4. Salman Khan, R. J. Choi, Dong-Ung Lee, Y. S. Kim. Sesquiterpenes derivatives isolated from Cyperus rotundus L. inhibits inflammatory signaling mediated by NF-κB pathway. *(1^st author)**	Natural Product Sciences, 17(3): 250-255. (Korea)	2011	00

PATENTS

S. N.	Description	Filing Date	App. No.
1.	Ihsan ul Haq, Salman Khan, Bushra Shal, Madiha Ahmed, Bushra Mirza, Tofeeq-Ur-Rehman (2021) Coagulansin-A attenuates pathology of Alzheimer’s disease	05-03-2021	192/2021
2.	Ihsan ul Haq, Salman Khan, Adnan Khan, Muhammad Waleed Baig, Madiha Ahmed, Bushra Mirza, Humaira Fatima (2021) Wthametelin ameliorates neuropathogenesis of multiple sclerosis	19-03-2021	222/2021
3.	Ihsan ul Haq, Salman Khan, Adnan Khan, Muhammad Waleed Baig, Madiha Ahmed, Bushra Mirza, Humaira Fatima (2021) Wthametelin alleviates neuropathic pain	27-04-2021	322/2021

PRESENTATIONS/CONFERENCES/WORKSHOPS

1. Salman Khan. Pain and Nanoparticles: molecular targets and mechanism. Fall International Convention of Pharmaceutical Society of Korea 21-23 October-2020, Korea {Virtual}.

2. Salman Khan. Vascular dysfunction and potential role of anti-inflammation in
neuropathic pain. 6th Annual Neuroscience Conference (6ANC) {Virtual}Agha Khan University, Saturday October 17, 2020, Karachi.

3. Salman Khan. Pharmacological evaluations and drug discovery from naturally isolated compound. 1^st National Conference on Current Updates in Pharmacy Profession and Research, July 29~30, 2019, COMSATS University Abbottabad, Pakistan.

4. Salman Khan. Pharmacological Mechanism Underlying Anti-inflammatory, Anti-nociceptive and Neuroprotective Activities of Anomalin. 3^rd International conference Recent Advancement in Pharmaceutical Research and Drug Delivery, February 19~20, 2019. QAU, Islamabad, Pakistan.

5. Salman Khan. Approach toward new drug development based on pharmacological evaluation from naturally isolated compounds. Proceeding of the 47^th Annual Meeting of the Korean Society of Pharmacognosy, The 10^th KSP-JSP-CJP joint symposium, Ehwa Women University, Seoul, December 22-23, 2018, South Korea

6. Salman Khan. Predominant role of vascular dysfunction and potential of anti-inflammation in alleviation of neuropathic pain. Asia PharmII (The 2^nd Asian conference of Pharmaceutical Sciences, Jun 2-22, 2017, Seoul, Korea.

7. Salman Khan, RJ Choi, JH Lee, YS Kim. Attenuation of neuropathic pain and neuroinflammatory responses by a pyranocoumarin derivative, anomalin in animal and cellular models. Proceeding of the 46^th Annual Meeting of the Korean Society of Pharmacognosy, Seoul, December 03, 2015, South Korea.

8. Salman Khan, R. J. Choi, O. Shehzad, H. P. Kim, M. N. Islam, J. S. Choi, and Y. S. Kim. Molecular mechanism of capillarisin-mediated inhibition of MyD88/TIRAP inflammatory signaling and its anti-hyperalgesic effect in an inflammatory pain models. 11^th CGCM meeting, August 20~24, 2012, Macau.

9. Salman Khan, E. M. Shin, Y. H. Jung, J. Kim, A. Tosun, Y. Shik Kim. Anomalin, pyranocoumarin inhibits LPS-induced expression of inflammatory mediators via NF-κB and MAP-kinase signaling pathways. 10^th CGCM meeting August 26~ 28, 2011, Shanghai, China.

10. Salman Khan, E. M. Shin, Y. H. Jung, J. Kim, Y. Shik Kim. Suppression of LPS-induced inflammatory and NF-κB responses by anomalin isolated from the root of Saphoshnikovia divaricata in RAW 264.7 macrophages. December 22-24, 2010 (Tokoshima), Japan.

11. Salman Khan, E. M. Shin, D-U. Lee, Y. S. Kim. Bioactivity guided evaluation of sesquiterpenes as an anti-inflammatory activity isolated from Cyperus rotundus L: Effect of chemical structures and cellular signaling pathway. 9^th CGCM meeting, 2010. Hong Kong.

POSTER PRESENTATIONS/ CONFERENCES

1. Salman Khan. COMSTECH online course entitled "Protozoan ’Drug’ Discovery: Old Drugs, New Targets and Mining for Novelty, Delivered by Prof. Dr. Paul W. Denny, August 6th, 2021.

2. Salman Khan. COMSTECH webinar “Online Meeting on Recent Developments in Drug Discovery and Medicinal Chemistry" on July 26-27, 2021.

3. Salman Khan. Online Meeting on Recent Developments in Drug Discovery and Medicinal Chemistry" on July 26-27, 2021, Islamabad, Pakistan

4. Salman Khan. 2^nd Global Virtual Conference on Neurodegenerative Diseases (GVCND-2021). Central European (Berlin, Rome, Stockholm, Vienna) January 28, 2021.

5. B Shal, A Khan, A Ullah Khan, Salman Khan. Neuroprotective effect of a triterpenoid derivative against CCl 4 -induced behavior alterations by targeting VEGF/BDNF and caspase-3 in mice. Autumn Meeting for Young Chemists in Biomedical Sciences (AMYC BIOMED) organized by Department of Excellence of Pharmacy (University of Naples Federico II. Italy), Oct 13-14, 2020.

6. A Khan, B Shal, A Ullah Khan, T Bibi, Salman Khan. Phytosteroid ameliorates the progression of motor/sensory symptoms in a mouse model of multiple sclerosis. Autumn Meeting for Young Chemists in Biomedical Sciences (AMYC BIOMED) organized by Department of Excellence of Pharmacy (University of Naples Federico II, Italy), Oct 13-14, 2020.

7. Salman Khan. 4th International Conference (Virtual) titled “Integrative multidisciplinary nanomedicine: a game changing strategy for emerging infectious disease” Department of Pharmacy, Quaid-i-Azam University in collaboration with ORIC QAU, Islamabad, Pakistan. October 10, 20120.

8. B Shal, A Khan, M Naveed, YS Kim, Salman Khan. Anti-anxiety and anti-depressant effect of a triterpenoid derivative against bacteria-induced behavioral alterations. in 6th international conference on Drug Development-Natural and Synthetic: Current approaches and emerging trends for the development and discovery of drugs being hosted by Centre for Advanced Drug Research (CADR), COMSATS University, Abbottabad on Nov 29-30, 2019.

9. A Ullah Khan, A Muhammad, A Khan, B Shal, MN Ahmad, A Aziz, Salman Khan. The newly synthesized N-Benzylidene-4-(2-HydroxyNaphthalene-1-yl) Diazenyl) Hydrazides (1-2) (NCHDH and NTHDH) compounds attenuates LPS-induced septicemia and multi-organ failure through HSP70/90 proteins and Nrf2 signaling. 6th international conference on Drug Development-Natural and Synthetic: Current approaches and emerging trends for the development and discovery of drugs being hosted by Centre for Advanced Drug Research (CADR), COMSATS University, Abbottabad on Nov 29-30, 2019.

10. A Khan, B Shal, A Ullah Khan, IU Haq, Salman Khan. Isowithametelin and Ajugarin-1 protects hippocampal neuronal cells against H2O2-induced damage through suppression of oxidative stress. (6th international conference on Drug Development-Natural and Synthetic: Current approaches and emerging trends for the development and discovery of drugs being hosted by Centre for Advanced Drug Research (CADR), COMSATS University, Abbottabad on Nov 29-30, 2019.

11. A Khan, B Shal, M Naveed, YS Kim, Salman Khan. Anxiolytic and antidepressant-like effects of matrine through inhibition of JNK-mediated inflammatory, ROS, and apoptotic signaling in animal model of burn injury. 3rd International Conference on “Recent Advancement in Pharmaceutical Research and Drug Delivery”, Department of Pharmacy, Quaid-i-Azam University, Islamabad on Feb 19-20, 2019.

12. Salman Khan. International Pharmacy Conference and Exhibition (IPCE), Jun 18~19, 2019, University of Swabi, KPK, Pakistan

13. Salman Khan. Pharmacological evaluations and drug discovery from naturally isolated compound. 1^st National Conference on Current Updates in Pharmacy Profession and Research, July 29~30, 2019 COMSATS University Abbottabad, Pakistan.

14. S Khalid, M Ziaullah, A Khan, R Afridi, h Rasheed, A Khan, H Ali, YS Kim, Salman Khan. Antihyperalgesic and antiallodynic properties of honokiol in acute and chronic models of inflammatory pain. 1^st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan.

15. A Khan, M Ziaullah, R Afridi, H Rasheed, S Khalid, H Ullah, YS Kim, Salman Khan. Anti-nociceptive properties of 25-MHA in CFA and carrageenan-induced in animal models. 1^st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan

16. H Rasheed, R Afridi, A Khan, M Ziaullah, S Khalid, A Atiq, H kashif, MN Ahmad, YS kim, Salman Khan. Anti‑infammatory and analgesic activities of 2‑(5‑me rcapto‑1,3,4‑oxadiazol‑2‑yl)‑N‑propylbenzenesulphonamide (MOPBS) in rodents. 1^st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan.

17. A Atiq, B Shal, M Naveed, A Khan, S Zeeshan, Salman Khan. Pharmacological evaluation of Silver sulfadiazine nanoparticles loaded Alovera encapsulated film on animal mode of wounds. 1^st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan.

18. M Naveed, S Zeeshan, A Khan, B Shal, A Atiq, Salman Khan. Anti-inflammatory, analgesic and antipyretic activities of newly synthesized hetroleptic palladium (II) complexes. 1^st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan.

19. S Zeeshan, M Naveed, A Khan, B Shal, H Rasheed, Salman Khan. Anti-inflamamtory and analgesic effect of novel palladium (II) complexes on animal models. 1^st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan

20. A Khan, B Shal, M Naveed, A Atiq, S Zeeshan, Salman Khan. Matrine ameliorates anxiety and depressive like behavior in carbon tetrachloride and burn-induced animal models. 1^st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan.

21. B Shal, A Khan, M Naveed, A Atiq, S Zeeshan, Salman Khan. Evaluation of pharmacological potential of 25-MHA in LPS and CCl4-induced anxiety and depression models. 1^st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan.

22. R Afridi, H Rasheed, A Khan, S Khalid, Z ullah, B Shal, H Jabeen, YS Kim, Salman Khan. Antihyperalgesic properties of Flavone derivative Poncirin in acute and chronic inflammatory pain models in mice. 1^st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan.

23. M Zeeshan, H Ali, M Arshad, MI Khan, M Mukhtar, Salman Khan. Design. Characterization and kinetics study of Glycyrrhizic acid loaded pH-sensitive PLGA nanoparticles for the potential drug targeting in inflammatory bowel disease. 1^st International conference on Advances in Drug Discovery and Development (ICAD3), 3-5 January, 2018, Islamabad Pakistan

24. Salman Khan. 2^nd international conference on recent innovations in pharmaceutical sciences (ICRIPS-2017), Organized by Riphah Institute of Pharmaceutical Sciences, November 15-16, 2017, Islamabad, Pakistan.

25. Salman Khan, O. Shehzad, J. Chun, and Y. S. Kim. Mechanism underlying anti-hyperalgesic and anti-allodynic properties of anomalin in both acute and chronic inflammatory pain models in mice through inhibition of NF-κB, CREB and MAPKs signaling cascades. Korean Society of Pharamcognosy 2012. 06. (Seoul, Korea).

26. Salman Khan, R. J. Choi, O. Shehzad, H. P. Kim, M. N. Islam, J. S. Choi, and Y. S. Kim. Molecular mechanism of capillarisin-mediated inhibition of MyD88/TIRAP inflammatory signaling and its anti-hyperalgesic effect in an inflammatory pain models. 11^th CGCM meeting August 20~24, 2012, Macau.

27. Salman Khan, E. M. Shin, S. W. Baek, J. Kim, Y. S. Kim. Novel labdan diterpene derivative isolated from Leonurus japonicum as a function of anti-inflammatory activity in LPS-stimulated RAW 264.7 cells. 9^th CGCM meeting, 2010, Hong Kong.

28. Salman Khan, E. M. Shin, Y. H. Jung, J. Kim, Y. S. Kim. Anti-inflammatory and anti-NF-κB effects of anomalin isolated from the root of Saposhnikovia divaricata in LPS-stimulated RAW264.7 macrophages. 9^th CGCM meeting, 2010, Hong Kong.

29. Salman Khan, E. M. Shin, Y. H. Jung, J. Kim, Y. Shik Kim. Suppression of LPS-induced inflammatory and NF-κB responses by anomalin isolated from the root of Saphoshnikovia divaricata in RAW 264.7 macrophages. December 22-24, 2010 (Tokoshima), Japan.

30. Salman Khan, O. Shehzad, T. Khan, J. K. Park, Investigation of flow pattern and volumetric oxygen transfer coefficient (KLa) for new bioreactors equipped with centrifugal impellers. Korean Society of Biotechnology and Bioprocess engineering (KSBB), 2008, Jinju S. Korea.

31. Salman Khan, O. Shehzad, T. Khan, J. K. Park, Treatment of Brewery Waste for the Improved Production of Bacterial Cellulose by a Gluconacetobacter Strain, Young Asian Biochemical Engineers’s Community 2007, (YABEC), Japan.

32. Salman Khan, O. Shehzad, T. Khan, J. K. Park, Evaluation of Autolyzed waste of beer fermentation broth as a basal medium for the production of bacterial cellulose and oligosaccharides Gluconacetobacter hansenii, Korean Institute of Chemical Engineers 2007 (KIChE-2007), Daejon, South Korea.

33. Salman Khan, O. Shehzad, T. Khan, J. K. Park, Production and structure feature of bacterial cellulose using nano-bubble system, Young Asian Biochemical Engineers’s Community 2008 (YABEC-2008), Japan.

34. Salman Khan, O. Shehzad, T. Khan, J. K. Park, Production of bacterial cellulose using waste from beer fermentation broth in shaking cultivation, Korean Society of Biotechnology and Bioprocess engineering (KSBB), 2008, Jeju do, S.Korea.

35. O. Shehzad, Salman Khan, T. Khan, J. K. Park, Production of Bacterial Cellulose membrane by G. hasenii using fed batch cultivation. (Korean Society of Biotechnology and Bioprocess engineering (KSBB), 2008, Jinju S. Korea.

36. O. Shehzad, Salman Khan, T. Khan, J. K. Park, Production of bacterial cellulose in fed batch cultivation using waste from beer fermentation broth. Korean Institute of Chemical Engineers (KIChE-2008), Pusan, Oct 22, 2008, South Korea.

37. O. Shehzad, Salman Khan, T. Khan, J. K. Park, Physico-Chemico-Mechanical characteristics of bacterial cellulose produced in fed batch cultivation using waste from beer fermentation broth. Korean Institute of Chemical Engineers (KIChE-2008), Pusan, Oct 22, 2008, South Korea.

Salman Khan, Y S Kim. Pharmacological Screening of KFDA samples (natural products) for anti-inflammatory, anti-nociceptive and behavioral pharmacological activities. Joint project between College of Pharmacy, Seoul National University, Seoul, Korea and Department of Pharmacy, QAU. From March 15, 2015~ March 10, 2019), Funded by National Research Foundation (NRF), South Korea.

Salman Khan (PI), Gul Majid Khan (Co-PI); “Evaluation of phenolic compounds effect on streptozotocin-induced diabetes and related neuropathic pain model in mice”, 2015-2016 HEC, Pakistan (Rs. 419000) Completed)

Salman Khan (Co-PI), Ji Zhang. Potential of anti-inflammation in relieving diabetic neuropathy. Neuroinflammation Training Program, McGill University, Montreal, Quebec, Canada, April 01, 2014~ April 30, 2015. (40000USD) Completed.

Salman Khan (PI), YS Kim (Co-PI). BK-21-plus, College of Pharmacy, Seoul National University, Seoul, South Korea, 2013~ 2014 (30000USA) Completed.

Salman Khan (PI), Hussain Ali (Co-PI). Therapeutic potential of anti-inflammation in attenuation of neurodegenerative diseases: molecular approach toward specific targets (NRPU-submitted to HEC, Pakistan)

Hussain Ali (PI), Salman Khan (Co-PI); “Preparation and characterization of drug loaded PLGA/pH- sensitive PLGA-nanoparticles for therapeutic applications”, HEC, Pakistan (ongoing)